Lazard Asset Management’s BlackRock Health Sciences Trust II BMEZ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$20.5M Buy
1,332,867
+711,263
+114% +$10.2M 0.03% 339
2026
Q1
$8.93M Buy
621,604
+243,054
+64% +$3.61M 0.01% 439
2025
Q4
$5.7M Buy
+378,550
New +$5.68M 0.01% 520
2025
Q2
Sell
-597,137
Closed -$8.9M 2306
2025
Q1
$8.9M Hold
597,137
0.01% 514
2024
Q4
$8.6M Sell
597,137
-107,026
-15% -$1.66M 0.01% 500
2024
Q3
$11.2M Sell
704,163
-94,799
-12% -$1.5M 0.01% 440
2024
Q2
$12.3M Hold
798,962
0.02% 480
2024
Q1
$13.1M Buy
798,962
+156,417
+24% +$2.47M 0.02% 469
2023
Q4
$9.41M Hold
642,545
0.01% 562
2023
Q3
$9.26M Buy
642,545
+498,079
+345% +$7.77M 0.01% 578
2023
Q2
$2.37M Hold
144,466
﹤0.01% 858
2023
Q1
$2.41M Sell
144,466
-20
-0% -$322 ﹤0.01% 875
2022
Q4
$2.23M Buy
144,486
+306
+0.2% +$4.74K ﹤0.01% 887
2022
Q3
$2.15M Hold
144,180
﹤0.01% 868
2022
Q2
$2.37M Buy
+144,180
New +$2.47M ﹤0.01% 869

Other funds holding BMEZ

Lazard Asset Management's BMEZ Position: Q2 2026 in Review

Lazard Asset Management increased its BlackRock Health Sciences Trust II (BMEZ) stake by 114% in Q2 2026, buying an estimated $10.2M and bringing the position to 1,332,867 shares worth $20.5M. The position accounts for 0.03% of the portfolio, ranked #339.

Lazard Asset Management first reported a position in BMEZ in Q2 2022 and has held it in 15 quarters since. 89 funds tracked by Wall St. Rank hold BMEZ as of Q2 2026.

  • Lazard Asset Management held 1,332,867 shares of BlackRock Health Sciences Trust II worth $20.5M as of Q2 2026.
  • Lazard Asset Management bought 711,263 BlackRock Health Sciences Trust II shares in Q2 2026, an estimated $10.2M.
  • BlackRock Health Sciences Trust II made up 0.03% of Lazard Asset Management's portfolio in Q2 2026, its #339 holding.
  • Lazard Asset Management first reported a position in BlackRock Health Sciences Trust II in Q2 2022 and has held it in 15 quarters since.
  • 89 funds tracked by Wall St. Rank held BlackRock Health Sciences Trust II as of Q2 2026.

Based on Lazard Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.